HSBC Bank Plc : Form 8.5 (EPT/RI) - Elis SA FORM 8.5

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
144
HSBC Bank Plc : Form 8.5 (EPT/RI) - Elis SA

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")

1.         KEY INFORMATION

(a) Name of exempt principal trader: HSBC BANK PLC
(b) Name of offeror/offeree in relation to whose relevant securities this form relates:   Use a separate form for each offeror/offeree   Elis SA
(c) Name of the party to the offer with which exempt principal trader is connected: Berendsen plc
(d) Date dealing undertaken: 30 th May 2017
(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer? Yes- Berendsen plc

2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a)        Purchases and sales

Class of relevant security Purchases/ sales   Total number of securities Highest price per unit paid/received (EUR) Lowest price per unit paid/received (EUR)
Ordinary Shares Purchase 3,726 19.44 19.42
Ordinary Shares Sale 3,726 19.57 19.34

(b)        Derivatives transactions (other than options)

Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit (EUR)
         

(c)        Options transactions in respect of existing securities

(i)         Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit
               

(ii)        Exercising

Class of relevant security Product description e.g. call option Number of securities Exercise price per unit
         

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable)
         

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

3.         OTHER INFORMATION (a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: If there are no such agreements, arrangements or understandings, state "none"
    None  

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i)  the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"
  None
Date of disclosure: 31 st May 2017
Contact name: Ray Onrubia
Telephone number: 0207 088 2000

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk .  The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

Scroll down for more posts ▼

Top 10 Most Recent News Articles

APEC Summit 2026: Shenzhen in the Spotlight

Updated Category News Views 35

An International Stage for Shenzhen Alright, folks, here's the deal. We’ve got the 2026 APEC Summit rolling into Shenzhen, perched right there in Guangdong Province, and the world’s eyes are glued to it. Happens November 18–19, and you better believe it’s a magnet for all things global. The China Media Group’s Chinese Global Program Center isn’t missing a...

Continue Reading
Innovent Unveils IAR177: A New Era In Rheumatology

Updated Category News Views 121

Setting the Stage for Rheumatic Disease Breakthroughs Innovent Biologics is coming out of the gates hot with its recent presentation at the ACR Convergence 2026, delivering some jaw-dropping preclinical data on its fledgling bispecific antibody, IAR177. Situated in Orlando, this showcase sounds like a real advancement in tackling the uphill battle of rheumatic diseases....

Continue Reading
Azitra Reports Q3 2026: Key Developments in Biopharma Pipeline

Updated Category News Views 49

Unpacking Azitra's Recent Breakthroughs Azitra, Inc. galloped into the spotlight with their Q3 2026 financials and some hefty business updates. This isn’t just about dollars and cents; they've got some fascinating biotech news wrapped in. Riding High on ATR-COSF Ex Vivo Results All eyes are on Azitra’s ATR-COSF. The lab is lighting up with news — a 50% wrinkle...

Continue Reading
SOCSA: The Future of Safety in Confined Spaces?

Updated Category News Views 5

Autonomous Tech Meets Safety Regulations Some days innovation hits like a ton of bricks, and here we go again—this time with a gizmo aiming to shake up the safety game in confined spaces. Enter the SOCSA, the Self Operating Confined Space Attendant, designed by a seasoned agriculture worker who's had a ringside seat to enough OSHA rule breaches to fill a book. But ain't...

Continue Reading
Biointron's RushDATA™: Speeding Up Antibody Discovery

Updated Category News Views 80

A New Chapter in Antibody Discovery Well, color me intrigued. Biointron, a name you'd recognize if you've got even a toe in the biotech pond, just threw a serious curveball into the antibody discovery game with RushDATA™—an AI- and machine learning-driven platform that's packing a punch. And it's not just about throwing tech buzzwords around; this thing clocks...

Continue Reading
SPOC Energy's Hiring Push Signals Growth Surge

Updated Category News Views 21

A Growing Workforce for a Growing Demand Here we are, smack dab in a bustling week of business news, and among it, SPOC Energy is ramping up its workforce across Alabama. Now, SPOC isn't any run-of-the-mill operation; this Birmingham-based manufacturer messes around with advanced power conversion systems and motor-control automation—a mouthful, sure, but critical stuff...

Continue Reading
Golden State Dermatology Expands with Sparks Clinic Launch

Updated Category News Views 90

Northern Nevada's New Name in Dermatology Take a stroll down Ion Drive in Sparks, and you'll find a fresh face in town—and we're not talking about a new coffee shop. Nope, it's something with a lot more skin in the game. Golden State Dermatology (GSD) is setting up shop at 5070 Ion Drive, Suite 201, and the doors are wide open for locals seeking dermatological care. A...

Continue Reading
Genesis One Rolls Out Telehealth Wellness Platform

Updated Category News Views 35

Genesis One Enters the Fray with Home-Based Wellness In a health industry where everyone's screaming for transparency and flexibility, Genesis One is finding a sweet spot. They're throwing their hat in the ring with a new telehealth wellness pitch. Now, this isn't your everyday launch—it's a prelude to a January 2027 rollout, with co-founders Brent Messer and Dr. Alex...

Continue Reading
Koppers Faces SEC Scrutiny After Earnings Miss

Updated Category News Views 36

Koppers' Third-Quarter Blues: Missing the Mark Koppers Holdings Inc. (NYSE: KOP) took a hard hit this quarter, missing Wall Street's earnings expectations by a mile. The adjusted earnings per share came in at just $0.77, while the suits down on Wall Street were expecting something closer to $1.34 to $1.37. Now, if you’re holding KOP in your portfolio, you're probably...

Continue Reading
Paris Baguette Opens New Café in Novato, CA

Updated Category News Views 12

Another Feather in Paris Baguette’s Cap Alright, as far as pastry shops go, Paris Baguette is rolling out those cinnamon rolls like they're planting flags on the moon. They've just added a new café in Novato, California, bringing the artisanal charm of their iconic baked goods to yet another American doorstep. A Local Affair with Big Aspirations The man of the hour,...

Continue Reading

Top 5 Most Recently Viewed Articles

Tesla's Innovative Response to California Wildfires Using Tech

Updated Category News Views 444

Tesla's Commitment to Community Support During Wildfires Tesla Inc (NASDAQ: TSLA) has recently made headlines for its proactive measures in response to wildfires devastating parts of California. CEO Elon Musk announced that the company's efforts would impact the delivery of Cybertrucks, which are highly anticipated by customers in the affected areas. The decision to delay...

Continue Reading
Aegon's Strong Q3 2024 Performance and Future Outlook

Updated Category News Views 553

Aegon's Impressive Performance in the Third Quarter Aegon has recently shared compelling updates about its performance in the third quarter of 2024, showcasing resilience and strategic growth plans despite fluctuating market conditions. The company reported an impressive operating capital generation of EUR 336 million, which reinforces its robust financial position and...

Continue Reading
Anticipating Earnings: The Future of Ribbon Communications

Updated Category News Views 230

Earnings Projection for Ribbon Communications Ribbon Communications (NASDAQ:RBBN) is gearing up to unveil its quarterly earnings report soon. Investors are watching closely, seeking signs that the company has not only met but exceeded expectations. According to forecasts, analysts predict an earnings per share (EPS) of approximately $0.05. This announcement is set to stir...

Continue Reading
Investors Urged to Examine Simulations Plus, Inc. Concerns

Updated Category News Views 187

Investigating Simulations Plus, Inc. for Securities Fraud Recent events have raised significant concerns regarding the financial practices of Simulations Plus, Inc. (NASDAQ: SLP), a prominent software firm specializing in the pharmaceutical and biotechnology sectors. This article explores the unfolding situation, which has financial implications for investors closely...

Continue Reading
NEXE Innovations Showcases Growth and Milestones in Food Safety

Updated Category News Views 247

NEXE Innovations Reports Strong Growth and Key Milestones NEXE Innovations Inc. (TSXV: NEXE) has recently released its financial results for the quarter that ended in August 2025. The company is making strides in the compostable materials sector and has showcased impressive growth metrics and operational achievements. Financial Highlights for Q1 2026 For the three-month...

Continue Reading